BRAF, a mitogenic Ser/Thr kinase in the MAPK/ERK pathway, has an activating mutation, V600E, in at least 50% of melanomas [218,219] and is thought to be a central oncogenic driver in melanoma. This evidence concerns the gene BRAF and melanoma.